• Best Practices New Normal
  • Digital Dentistry
  • Data Security
  • Implants
  • Catapult Education
  • COVID-19
  • Digital Imaging
  • Laser Dentistry
  • Restorative Dentistry
  • Cosmetic Dentistry
  • Periodontics
  • Oral Care
  • Evaluating Dental Materials
  • Cement and Adhesives
  • Equipment & Supplies
  • Ergonomics
  • Products
  • Dentures
  • Infection Control
  • Orthodontics
  • Technology
  • Techniques
  • Materials
  • Emerging Research
  • Pediatric Dentistry
  • Endodontics
  • Oral-Systemic Health

Time in the Market: More Important than Timing the Market

Feature
Article

Despite watching the market rise, the bigger issue with transitioning your portfolio to cash is that, when trying to time the markets, you must be right twice.

stock, investing, market high, market low

Most US stock indices are at all-time highs, but what does that mean for your investments and your wealth? Should you liquidate your portfolios to avoid a potential “imminent” economic collapse? Do markets always fall after reaching all-time highs? If you pay attention to financial media or even mainstream media — you may start to think you must do something.

Regrettably, we do not have a crystal ball that tells us when the markets will shift. Nobody else does either. Unless someone is intimately familiar with your portfolio and your investments, you should not listen to advice about when to jump out of (or back in) the market. Your time in the market is far more important than timing the market highs and lows.

We believe markets are usually, but not always, efficient. The Oracle of Omaha, Warren Buffett, puts it well when he refers to the manic-depressisive nature of Mr. Market — despite all the information that investors have at their fingertips, irrational greed and fear occasionally drive the market for financial assets.

Should you cash out now while you’re ahead? Stock markets may continue to move higher and extend gains. If investors decide to move their portfolios to cash, they must be prepared to sit and watch on the sidelines if the market continues to reach potential new highs.

Even if you are okay watching the market rise, the bigger issue with transitioning your portfolio to cash is that, when trying to time the markets, you must be right twice. You must accurately predict the market high (when to jump out) AND predict the market low (when to jump back in). Nobody has been able to do this with any consistency in the history of the financial markets.

Also, take into consideration that money sitting idly in bank accounts is currently earning minimal interest. You can argue that you would actually lose money in the current environment because of inflation. The real rate of return for an investor earning only 0.5% in interest while inflation sits near 2% is negative.

“Forgoing returns in the interest of safety simply won’t deliver the returns you need to achieve your long-term goals,” says Rob Kapito, president and director, Blackrock. “In fact, it would take a US investor 35 years to double his or her money in cash, assuming a long-term expected return of 2%.”

Cash also presents a psychological challenge: once you’ve exited the stock market and stocks begin to fall, there will always be reasons to talk yourself into staying out. In hindsight, there was no white flag waved in March 2009 when the markets reached the low point of the financial crisis. There was no sign telling everyone it was safe to get back in the water. No one can consistently call tops and bottoms, so you should have an investment process in place that provides some level of comfort across many market scenarios.

“It’s about having the ability to get over the fear of allowing market forces to stop you from implementing an investment plan,” Ben Carlson recently explained. “Whatever you choose to do — dollar cost average over time, wait for a market correction, put it all back in at once, hire a professional — try to have a plan of attack that you can follow.”

We only deviate from our strategic investment planning, and baseline allocation if there is a compelling opportunity or reason to increase return and/or reduce risk.

Stock prices have historically risen, and all-time highs are challenged decade after decade.

“That is as true today as it was on Sept. 3, 1929, Jan. 11, 1973, Jan. 14, 2000, and Oct. 9, 2007,” Charlie Bilello explains. “Unfortunately, no one rang a bell at these all-time high tops, alerting you that there would be no new highs for years to come. The same will be true today. There will be another large correction, and it will start with an all-time high that looks and feels innocuous. No bell will be rung.”

We are not confident in our ability (or anyone’s) to consistently assess short-term psychological influences. We cannot time the markets — so we don’t try. But we are confident that over longer periods, valuations and fundamentals converge. Stay your course and stick to your plan. The authors welcome your questions.

SPECIAL OFFERS: To receive free hard copies of For Doctors Only: A Guide to Working Less and Building More and Wealth Management Made Simple please call 877-656-4362. Visit www.ojmbookstore.com and enter promotional code PHYMON04 for a free ebook download of these books for your Kindle or iPad.

Jason M. O’Dell, MS, CWM is a financial consultant and author of more than a dozen books for physicians, including For Doctors Only: A Guide to Working Less and Building More and Wealth Management Made Simple. He is also a principal of the wealth management firm OJM Group, where Adam Braunscheidel is a wealth advisor. They can be reached at 877-656-4362 or odell@ojmgroup.com.

Disclosure:

OJM Group, LLC. (“OJM”) is an SEC registered investment adviser with its principal place of business in the State of Ohio. OJM and its representatives are in compliance with the current notice filing and registration requirements imposed upon registered investment advisers by those states in which OJM maintains clients. OJM may only transact business in those states in which it is registered, or qualifies for an exemption or exclusion from registration requirements. For information pertaining to the registration status of OJM, please contact OJM or refer to the Investment Adviser Public Disclosure web site (www.adviserinfo.sec.gov).

For additional information about OJM, including fees and services, send for our disclosure brochure as set forth on Form ADV using the contact information herein. Please read the disclosure statement carefully before you invest or send money.

This article contains general information that is not suitable for everyone. The information contained herein should not be construed as personalized legal or tax advice. There is no guarantee that the views and opinions expressed in this article will be appropriate for your particular circumstances. Tax law changes frequently, accordingly information presented herein is subject to change without notice. You should seek professional tax and legal advice before implementing any strategy discussed herein. Some of the content for this article was developed by third parties and is provided for informational purposes only. While OJM Group deems such content to be reliable, OJM Group cannot guarantee its accuracy and disclaims any liability for reliance on any third party content. Sample cases above are for illustrative purposes only.

Related Videos
2024 Dental Products Report Spring Selection Bracket Reveal Video
Process of Care Workflow and Repairing Early Caries with Guided Enamel Remineralization
Addressing Unmet Needs in Early Childhood Oral Care - an interview with Ashlet Lerman, DDS
Mastermind Episode 33 – Charting the Course for the Future of Dentistry
CDS 2024 Midwinter Meeting – Interview with Debbie Zafiropoulos, who discusses a trio of new infection control products from Armis Biopharma.
2024 Chicago Dental Society Midwinter Meeting – Interview with Peter Maroon, business development and sales lead at Spectrum Solutions® on the new salivary diagnostic test, SimplyPERIO.
CDS 2024: Ivoclar's e.max ZirCAD Prime Blocks with Shashi Singhal, BDS, MS
CDS 2024: Diving Deep on J. Morita's New Root ZX3 & HF Module
CDS 2024: What's New at TAG University? with Andrew De la Rosa, DMD
© 2024 MJH Life Sciences

All rights reserved.